According to Alembic Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.33. In 2022 the company made an earnings per share (EPS) of $0.13 a decrease over its 2021 EPS that were of $0.49.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.33 | 151.29% |
2022 | $0.13 | -73.58% |
2021 | $0.49 | -38.83% |
2020 | $0.81 | 46.76% |
2019 | $0.55 | 30.23% |
2018 | $0.42 | 24.72% |
2017 | $0.34 | 6.71% |
2016 | $0.32 | -43.88% |
2015 | $0.56 | 138.06% |
2014 | $0.24 | 23% |
2013 | $0.19 |